# Glow

> Combination — not ranked · Combos · reviewed 2026-11-08
> Source page: https://peptidemeta.com/p/glow/

## Quick answers

**What is Glow?**

A skin-focused blend; in this catalog it means GHK-Cu combined with glutathione. Per this catalog: GHK-Cu (copper tripeptide) plus glutathione, sometimes with other peptides. Commercial products sold as “GLOW” vary, and some contain BPC-157 and TB-500 instead.

**What is in Glow?**

Glow typically combines GHK-Cu and Glutathione. Commercial products vary.

**How strong is the evidence for Glow?**

It is not ranked. A PubMed search found no published studies of this combination; only reviews mention it. GHK-Cu is supported mostly by lab and topical-skin studies; glutathione has RCTs as a supplement.

**Is Glow FDA-approved?**

No. Glow is not an approved product; no regulator has reviewed the combination.

**Is Glow banned in sport?**

Yes. Glow is prohibited in sport by the World Anti-Doping Agency under S0 (non-approved substances).

**How does Glow work?**

The Glow blend combines GHK-Cu-mediated collagen stimulation and extracellular matrix remodeling with glutathione-driven antioxidant protection and melanin modulation. GHK-Cu activates metalloproteinases for skin remodeling while glutathione neutralizes ROS and inhibits tyrosinase, producing complementary skin-brightening and anti-aging effects.

**What is known about the safety of Glow?**

Individual components (GHK-Cu, glutathione) have well-documented safety profiles. Combination-specific safety data not available.

## Key facts

- **Evidence tier:** not ranked
- **FDA:** not approved
- **WADA:** prohibited (S0)
- **Peptide:** yes
- **Routes studied:** Subcutaneous, Intramuscular
- **Components:** GHK-Cu, Glutathione

## Overview

A skin-focused blend; in this catalog it means GHK-Cu combined with glutathione. Commercial products sold as “Glow” vary, and some instead combine GHK-Cu with BPC-157 and TB-500. Promoted for collagen support, oxidative protection, and skin radiance.

## Mechanism

The Glow blend combines GHK-Cu-mediated collagen stimulation and extracellular matrix remodeling with glutathione-driven antioxidant protection and melanin modulation. GHK-Cu activates metalloproteinases for skin remodeling while glutathione neutralizes ROS and inhibits tyrosinase, producing complementary skin-brightening and anti-aging effects.

## Effects reported in research

_Reported outcomes, not promises; see the evidence tier._

- Enhanced skin luminosity and tone
- Increased collagen production
- Reduced oxidative skin damage
- Improved skin hydration and elasticity

## Safety & unknowns

Individual components (GHK-Cu, glutathione) have well-documented safety profiles. Combination-specific safety data not available. Proprietary formulation varies by provider. Side effects expected to mirror those of individual components. Not FDA-approved as a combination.

## Studies

- Pickart L, Vasquez-Soltero JM, Margolina A. (2015). *GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration*. BioMed Research International. Review. https://pubmed.ncbi.nlm.nih.gov/26236730/
  Review of the GHK-Cu component, covering its proposed roles in wound healing, collagen and glycosaminoglycan synthesis, and metalloproteinase regulation.
- Richie JP Jr, Nichenametla S, Neidig W, et al. (2015). *Randomized controlled trial of oral glutathione supplementation on body stores of glutathione*. European Journal of Nutrition. Clinical trial. https://pubmed.ncbi.nlm.nih.gov/24791752/
  RCT on the glutathione component alone: 6 months of oral glutathione raised body glutathione stores; it did not study the blend.

## Status sources

- [Pickart et al. 2015 — GHK and skin regeneration (review)](https://pubmed.ncbi.nlm.nih.gov/26236730/)
- [Richie et al. 2015 — RCT of oral glutathione](https://pubmed.ncbi.nlm.nih.gov/24791752/)
- [WADA 2026 Prohibited List — S0 covers unapproved substances such as injectable GHK-Cu](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf)

---

Educational reference only — not medical advice. No dosing information is published. Tiers rate the strength of published evidence, not effectiveness or safety.